• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


107.2000 SEK 0.2000 0.19%

As of 11:29:59 ET on 07/29/2014.

Snapshot for Meda AB (MEDAA)

Open: 107.7000 Day's Range: 106.8000 - 107.7000 Volume: 285,526
Previous Close: 107.4000 52wk Range: 69.7000 - 129.9000 1-Yr Rtn: +41.71%

Stock Chart for MEDAA

No chart data available.
  • MEDAA:SS 107.2000
  • 1D
  • 1M
  • 1Y
Interactive MEDAA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEDAA

Current P/E Ratio (ttm) 37.8141
Estimated P/E(12/2014) 10.9668
Relative P/E vs. OMX 2.3825
Earnings Per Share (SEK) (ttm) 2.8349
Est. EPS (SEK) (12/2014) 9.7750
Est. PEG Ratio 0.4931
Market Cap (M SEK) 32,400.46
Shares Outstanding (M) 302.24
30 Day Average Volume 573,388
Price/Book (mrq) 2.0746
Price/Sale (ttm) 2.4398
Dividend Indicated Gross Yield 2.33%
Cash Dividend (SEK) 2.5000
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 27.23%
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEDAA

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MEDAA

Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.

Henrik StenqvistExec VP/CFOMaria CarellExec VP:North America
Dirk GroenExec VP:Marketing OTCErik HaefflerExec VP:Manufacturing
More Company Profile & Key Executives for MEDAA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil